Development and Validation of the Minnesota Assessment of Pharmacogenomic Literacy (MAPL).

ABSTRACT: Ensuring that patients have an adequate understanding of pharmacogenomic (PGx) test results is a critical component of implementing precision medicine into clinical care. However, no PGx-specific validated literacy assessment has yet been developed. To address this need, we developed and validated the Minnesota Assessment of Pharmacogenomic Literacy (MAPLTM). Foundational work included a scoping review of patient and general public attitudes and experiences with pharmacogenomic testing, three focus groups, readability assessments, and review by experts and members of the general public. This resulted in a 15-item assessment designed to assess knowledge in four domains: underlying concepts, limitations, benefits, and privacy. For validation, 646 participants completed the MAPL as a part of

SUBMITTER: Allen JD 

PROVIDER: S-EPMC9506235 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature